Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,173,995 |
|
|||||
| News | - | ||||||
| Day High | 1.15 | Low High |
|||||
| Day Low | 0.83 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ADC Therapeutics SA | ADCT | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.28 | 33.73% | 1.11 | 16:39:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.83 | 0.83 | 1.15 | 1.11 | 0.83 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,726 | 1,173,995 | $ 1.00 | $ 1,178,868 | - | 0.359908 - 5.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:37:00 | 14 | $ 1.10 | USD |
ADC Therapeutics SA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 89.51M | 80.64M | - | 209.91M | -155.8M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ADC Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADCT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.69 | 1.15 | 0.6883 | 0.7998831 | 322,700 | 0.42 | 60.87% |
| 1 Month | 0.7031 | 1.15 | 0.359908 | 0.6533334 | 384,754 | 0.4069 | 57.87% |
| 3 Months | 1.08 | 1.15 | 0.359908 | 0.7470432 | 308,135 | 0.03 | 2.78% |
| 6 Months | 2.35 | 2.64 | 0.359908 | 1.35 | 387,648 | -1.24 | -52.77% |
| 1 Year | 3.69 | 5.75 | 0.359908 | 2.47 | 548,701 | -2.58 | -69.92% |
| 3 Years | 37.33 | 38.34 | 0.359908 | 10.02 | 357,852 | -36.22 | -97.03% |
| 5 Years | 30.00 | 56.5899 | 0.359908 | 12.83 | 337,154 | -28.89 | -96.3% |
ADC Therapeutics Description
| ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. |
